标题
Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2
作者
关键词
-
出版物
eLife
Volume 11, Issue -, Pages -
出版商
eLife Sciences Publications, Ltd
发表日期
2022-03-25
DOI
10.7554/elife.74877
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Montelukast in hospitalized patients diagnosed with COVID-19
- (2021) Ahsan R. Khan et al. JOURNAL OF ASTHMA
- Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors
- (2021) Chunlong Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Screening of drug databank against WT and mutant main protease of SARS-CoV-2: Towards finding potential compound for repurposing against COVID-19
- (2021) Tanuj Sharma et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression
- (2021) Ke Zhang et al. Science Advances
- gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS
- (2021) Mario S. Valdés-Tresanco et al. Journal of Chemical Theory and Computation
- Emerging Mutations in Nsp1 of SARS-CoV-2 and Their Effect on the Structural Stability
- (2021) Kejie Mou et al. Pathogens
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2
- (2020) Matthias Thoms et al. SCIENCE
- Taming the cytokine storm: repurposing montelukast for the attenuation and prophylaxis of severe COVID-19 symptoms
- (2020) Nitesh Sanghai et al. DRUG DISCOVERY TODAY
- The coding capacity of SARS-CoV-2
- (2020) Yaara Finkel et al. NATURE
- SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation
- (2020) Katharina Schubert et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- GESS: a database of global evaluation of SARS-CoV-2/hCoV-19 sequences
- (2020) Shuyi Fang et al. NUCLEIC ACIDS RESEARCH
- Growth, detection, quantification, and inactivation of SARS-CoV-2
- (2020) James Brett Case et al. VIROLOGY
- SARS-CoV-2 nsp1: Bioinformatics, Potential Structural and Functional Features, and Implications for Drug/Vaccine Designs
- (2020) Yuan-Qin Min et al. Frontiers in Microbiology
- Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA
- (2020) Shuai Yuan et al. MOLECULAR CELL
- The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation
- (2020) Antonin TIDU et al. RNA
- CASTp 3.0: computed atlas of surface topography of proteins
- (2018) Wei Tian et al. NUCLEIC ACIDS RESEARCH
- ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB
- (2015) James A. Maier et al. Journal of Chemical Theory and Computation
- Definition and testing of the GROMOS force-field versions 54A7 and 54B7
- (2011) Nathan Schmid et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Montelukast in asthma: a review of its efficacy and place in therapy
- (2010) Pierluigi Paggiaro et al. Therapeutic Advances in Chronic Disease
- Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells
- (2008) K. Narayanan et al. JOURNAL OF VIROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started